Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 31Nausea 27Neoplasms 14Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Acute 7Multiple Myeloma 6Breast Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Burkitt Lymphoma 5Sezary Syndrome 4Primary Myelofibrosis 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myeloproliferative Disorders 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Hairy Cell 4Hodgkin Disease 4Uterine Cervical Neoplasms 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Anaplastic 3

Interventions

Radiotherapy 10Cisplatin 9pembrolizumab 6Surveys and Questionnaires 6Methods 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 5fludarabine 4Papillomavirus Vaccines 4Early Intervention, Educational 4Cyclophosphamide 4Brachytherapy 4durvalumab 3aldesleukin 3Vaccines, Synthetic 3Vaccines 3Sentinel Lymph Node Biopsy 3Radiosurgery 3Radiation 3Platinum 3Palliative Care 3Paclitaxel 3Nivolumab 3Indocyanine Green 3Gemcitabine 3Drug Therapy 3Carboplatin 3Bleomycin 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3tremelimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Ondansetron × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡